Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursion Pharmaceuticals (NASDAQ:RXRX) outlined progress across its clinical pipeline, drug-discovery partnerships and ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Recursion Pharmaceuticals, Inc. reported its Q2 2026 results, with revenue falling to US$7.67 million from US$19.22 million a ...

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...

ISC Class 12 Computer Science Syllabus: The CISCE (Council for the Indian School Certificate Examinations) has released the latest Class 12 Computer Science syllabus for the 2026-27 board exam. The ...

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

Google DeepMind warns AI capex is paving the way for recursive self-improvement (RSI) as hyperscalers ramp spending.

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not ...

Anthropic employee retention leads every frontier AI lab at 80%, yet CEO Dario Amodei has reportedly expressed concern that ...